
Episode 23: A Between the Biotech Waves conversation with Jim Birchenough, Vice Chair of Wells Fargo Biopharmaceutical Inv Banking
Between the Biotech Waves
00:00
Is the Consolidation Making Healthier Companies?
One of the ways we talked about that, not from a dilutive standpoint, but making healthier companies was this concept of consolidation. M1 plus 1 equals 3. Have you seen that be realized? And to the extent that it's been realized, have we seen it actually be productive and the market respond to it? And is it to the extent you would have expected or you had expected middle of last year? Yeah, without getting into specific details, I would say we have seen some peer-to-peer mergers where this idea of, you know, one company has cash, runway, and the capabilities,. You put them together, we're seeing those kind of transactions relatively well
Transcript
Play full episode